The killer cell immunoglobulin-like receptor (KIR) genomic region: Gene-order, haplotypes and allelic polymorphism

Immunological Reviews

Volumn 190, Issue , 2002, Pages 40-52

  Hsu, Katharine C ^a   Chida, Shohei ^b   Geraghty, Daniel E ^b   Dupont, Bo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; CENTROMERE; DISEASE PREDISPOSITION; GENE DUPLICATION; GENE ORDER; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN GENOME; IMMUNOGENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; SEGREGATION ANALYSIS; TELOMERE;

ALLELES; ANIMALS; BONE MARROW TRANSPLANTATION; CHROMOSOME MAPPING; GENE FREQUENCY; GENOME; HAPLOTYPES; HUMANS; KILLER CELLS, NATURAL; MICE; MODELS, IMMUNOLOGICAL; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC;

EID: 0036945657     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2002.19004.x     Document Type: Review

References (84)

1. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense. function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
2. Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001;13:458-464.
3. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-393.
4. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904.
5. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001;19:291-330.
6. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
7. Ljunggren HG, Sturmhofel K, Wolpert E, Hammerling GJ, Karre K. Transfection of β2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants. J Immunol 1990;145:380-386.
8. Hoglund P, Ljunggren HG, Karre K, Jay G. Role of major histocompatibility complex dass-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice. Immunol Res 1990;9:298-313.
9. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001;413:165-171.
10. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000;1:119-126.
11. Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA 2001;98:11521-11526.
12. Cerwenka A, et al. Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D. J Immunol 2002;168:3131-3134.
13. + IL-2-activated natural killer cells. Nature 1992;358:66-70.
14. Daniels BF, Karlhofer FM, Seaman WE, Yokoyama WM. A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med 1994;180:687-692.
15. Correa I, Raulet DH. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 1995;2:61-71.
16. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991;253:199-202.
17. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:405-408.
18. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol 1995;155:2306-2310.
19. Wagtmann N, et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995;2:439-449.
20. Barten R, Torkar M, Haude A, Trowsdale J, Wilson MJ. Divergent and convergent evolution of NK-cell receptors. Trends Immunol 2001;22:52-57.
21. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001;15:363-374.
22. Makrigiannis AP, Pau AT, Schwartzberg PL, McVicar DW, Beck TW, Anderson SK. A BAC of the Ly49 gene cluster in 129 contig map mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics 2002;79:437-444.
23. Wilson MJ, et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 2000;97:4778-4783.
24. Westgaard IH, Berg SF, Orstavik S, Fossum S, Dissen E. Identification of a human member of the Ly-49 multigene family. Eur J Immunol 1998;28:1839-1846.
25. Barten R, Trowdale J. The human Ly-49L gene. Immunogenetics 1999;49:731-734.
26. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002;20:217-251.
27. Khakoo SI, et al. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 2000;12:687-698.
28. Rajalingam R, Hong M, Adams EJ, Shum BP, Guethlein LA, Parham P. Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes. J Exp Med 2001;193:135-146.
29. Canavez F, et al. Comparison of chimpanzee and human leukocyte Ig-like receptor genes reveals framework and rapidly evolving genes. J Immunol 2001;167:5786-5794.
30. Hershberger KL, Shyam R, Miura A, Letvin NL. Diversity of the killer cell Ig-like receptors of rhesus monkeys. J Immunol 2001;166:4380-4390.
31. McQueen KL, Wilhelm BT, Harden KD, Mager DL. Evolution of NK receptors: a single Ly49 and multiple KIR genes in the cow. Eur J Immunol 2002;32:810-817.
32. Strong SJ, et al. A novel multigene family encodes diversified variable regions. Proc Natl Acad Sci USA 1999;96:15080-15085.
33. Yoder JA, et al. Immune-type receptor genes in zebrafish share genetic and functional properties with genes encoded by the mammalian leukocyte receptor cluster. Proc Natl Acad Sci USA 2001;98:6771-6776.
34. Hawke NA, et al. Extraordinary variation in a diversified family of immune-type receptor genes. Proc Natl Acad Sci USA 2001;98:13832-13837.
35. andelboim O, et al. Enhancement of class II-restricted T cell responses by co-stimulatory NK receptors for class I MHC proteins. Science 1996;274:2097-2100.
36. Campbell KS, Cella M, Carretero M, Lopez-Botet M, Colonna M. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex. Eur J Immunol 1998;28:599-609.
37. Katz G, Markel G, Mizrahi S, Arnon TI, Mandelboim O. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. J Immunol 2001;166:7260-7267.
38. Kim J, Chwae YJ, Kim MY, Choi IH, Park JH, Kim SJ. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. J Immunol 1997;159:3875-3882.
39. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998;161:571-577.
40. Vales-Gomez M, Reyburn HT, Erskine RA, Strominger J. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Natl Acad Sci USA 1998;95:326-331.
41. Bottino C, et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 1996;26:1816-1824.
42. Brown MG, et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001;292:934-937.
43. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002;296:1323-1326.
44. Braud VM, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391:795-799.
45. Lee N, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998;95:5199-5204.
46. Colonna M, et al. A common inhibitory receptor for major histocompatibillty complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997;186:1809-1818.
47. Gomez-Lozano N, Gardiner CM, Parham P, Vilches C. Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics 2002;54:314-319.
48. Gassner C, et al. Sequencing of a complete long KIR haplotype from chromosome 19: a derivation of tools for the precise identification of KIR haplotypes from genomic DNA. Genomics, in press.
49. Uhrberg M, et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997;7:753-763.
50. Valiante NM, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997;7:739-751.
51. Crum KA, Logue SE, Curran MD, Middleton D. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 2000;56:313-326.
52. Norman PJ, Stephens HA, Verity DH, Chandanayingyong D, Vaughan RW. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 2001;52:195-205.
53. Norman PJ, et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun 2002;3:86-95.
54. Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 1999;68:1784-1789.
55. Toneva M, et al. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 2001;57:358-362.
56. Martin AM, Freitas EM, Witt CS, Christiansen FT. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics 2000;51:268-280.
57. Hsu KC, Liu X-R, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content. evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002;169:5123-5134.
58. Selvakumar A, Steffens U, Dupont B. NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains. Tissue Antigens 1996;48:285-294.
59. Rajagopalan S, Fu J, Long EO. Cutting edge: induction of IFN-γ production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 2001;167:1877-1881.
60. Faure M, Long EO KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol 2002;168:6208-6214.
61. Shilling HG, et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immun 2002;168:2307-2315.
62. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002;54:221-229.
63. Vilches C, Gardiner CM, Parham P. Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J Immun 2000;165:6416-6421.
64. Yang SY, Milford E, Hammerling U, Dupont B. Description of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system: the B-cell line panel designed for the Tenth International Histocompatibility Workshop. In: Dupont B, ed. Immunobiology of HLA, Vol. I. Histocompatibility Testing 1987. New York: Springer-Verlag, 1989: 11-19.
65. Steffens U, Vyas Y, Dupont B, Selvakumar A. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR). Tissue Antigens 1998;51:398-413.
66. Gardiner CM, et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 2001;166:2992-3001.
67. Vilches C, Pando MJ, Rajalingam R, Gardiner CM, Parham P. Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR 'B' haplotypes. Tissue Antigens 2000;56:453-456.
68. Rajalingam R, Gardiner CM, Canavez F, Vilches C, Parham P. Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. Tissue Antigens 2001;57:22-31.
69. Chwae Yj, ChoSe Kim SJ, Kim J. Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual. Immunol Lett 1999;68:267-274.
70. Vyas Y, Selvakumar A, Steffens U, Dupont B. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual. Tissue Antigens 1998;52:510-519.
71. Kwon D, Chwae YJ, Choi IH, Park JH, Kim SJ, Kim J. Diversity of the p70 killer cell inhibitory receptor (KIR3DL) family members in a single individual. Mol Cells 2000;10:54-60.
72. Shilling HG, Wienert-Weidenbach K, Valiante NM, Uhrberg M, Parham P. Evidence for recombination as a mechanism for KIR diversification. Immunogenetics 1998;48:413-416.
73. MHC Sequencing Consortium. Complete sequence and gene map of a human major histocompatibility complex (MHC). Nature 1999;401:921-923.
74. Snyder GA, Brooks AG, Sun PD. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc Natl Acad Sci USA 1999;96:3864-3849.
75. Fan QR, Long EO, Wiley DC. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2001;2:452-460.
76. Torkar M, Norgate Z, Colonna M, Trowsdale J, Wilson MJ. Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex. Eur J Immunol 1998;28:3959-3967.
77. Martin MP, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genet 2002;31:429-434.
78. Flores-Villanueva PO, et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci USA 2001;98:5140-5145.
79. Yen JH, et al. Major histocompability complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001;193:1159-1167.
80. Martin MP, et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002;169:2818-2822.
81. Anasetti C, et al. Marrow transplantation from unrelated volunteer donors. Annu Rev Med 1995;46:169-179.
82. Yu YY, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 1992;10:189-213.
83. Ruggeri L, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097-2100.
84. Chida S, Yamashita T, Güthrie B, Hansen JA, Geraghty DE. An association study between killer cell immunoglobhn-like receptor (KIR) genes and unrelated bone marrow transplant graft rejection. Tissue Antigens 2002;59:s27.